Tychos Therapeutics

India Founded: 2018 • Age: 8 yrs
Specializes in RD and manufacturing of drugs across multiple therapeutic areas.
Annual revenue $903,890 Latest available
Total funding - Funding intelligence
Employees 12 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Tychos Therapeutics

Tychos Therapeutics is a company based in India founded in 2018. It operates as a B2B. The company has 12 employees as of March 31, 2024. Tychos Therapeutics operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter India
  • Employees 12 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Tychos Therapeutics Private Limited
  • Date of Incorporation 15 Dec, 2003
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $903.89 K (USD)
    -4.43
    as on Mar 31, 2024
  • Net Profit
    $20.28 K (USD)
    7.8
    as on Mar 31, 2024
  • EBITDA
    $89.65 K (USD)
    1.21
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    12

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Tychos Therapeutics

Premium access

Detailed funding history for Tychos Therapeutics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Tychos Therapeutics

Investments
Premium access

Investment portfolio details for Tychos Therapeutics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Tychos Therapeutics

Premium access

Detailed financials for Tychos Therapeutics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Tychos Therapeutics Comparisons

Tychos Therapeutics Primary company
Description
Specializes in R&D and manufacturing of drugs across multipl...
Location
India
Founded Year
2018
Annual Revenue
$903.89 K (USD)
Net Profit
$20.28 K (USD)
EBITDA
$89.65 K (USD)
Employees
12
As of 2024
Premium access

Peer comparison for Tychos Therapeutics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Tychos Therapeutics

Tychos Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Tychos Therapeutics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Tychos Therapeutics

Premium access

Complete news archive for Tychos Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tychos Therapeutics

Tychos Therapeutics was founded in 2018.

Tychos Therapeutics is headquartered in India.

As of Mar 31, 2024, the latest employee count at Tychos Therapeutics is 12.

Annual revenue of Tychos Therapeutics is $903.89K as on Mar 31, 2024.

Tychos Therapeutics, established in 2018, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd and therapeutics. Specializes in RD and manufacturing of drugs across multiple therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Tychos Therapeutics's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available